204 related articles for article (PubMed ID: 20493569)
1. The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome.
Lassen P
Radiother Oncol; 2010 Jun; 95(3):371-80. PubMed ID: 20493569
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous human papillomavirus in head and neck squamous cell carcinomas.
Lindel K; Helmke B; Simon C; Weber KJ; Debus J; de Villiers EM
Cancer Invest; 2009 Aug; 27(7):781-7. PubMed ID: 19513898
[TBL] [Abstract][Full Text] [Related]
3. The role of human papillomavirus in head and neck cancer.
Lajer CB; von Buchwald C
APMIS; 2010 Jun; 118(6-7):510-9. PubMed ID: 20553531
[TBL] [Abstract][Full Text] [Related]
4. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
[TBL] [Abstract][Full Text] [Related]
5. Unravelling the biology of human papillomavirus (HPV) related tumours to enhance their radiosensitivity.
Vozenin MC; Lord HK; Hartl D; Deutsch E
Cancer Treat Rev; 2010 Dec; 36(8):629-36. PubMed ID: 20417037
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
7. Human papilloma virus in head and neck cancer: the need for a standardised assay to assess the full clinical importance.
Braakhuis BJ; Brakenhoff RH; Meijer CJ; Snijders PJ; Leemans CR
Eur J Cancer; 2009 Nov; 45(17):2935-9. PubMed ID: 19766476
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of human papillomavirus and other risk factors in Lithuanian patients with head and neck cancer.
Gudleviciene Z; Smailyte G; Mickonas A; Pikelis A
Oncology; 2009; 76(3):205-8. PubMed ID: 19209011
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus genome detection by in situ hybridization in fine-needle aspirates of metastatic lesions from head and neck squamous cell carcinomas.
Umudum H; Rezanko T; Dag F; Dogruluk T
Cancer; 2005 Jun; 105(3):171-7. PubMed ID: 15822131
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications.
Chung CH; Gillison ML
Clin Cancer Res; 2009 Nov; 15(22):6758-62. PubMed ID: 19861444
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
[TBL] [Abstract][Full Text] [Related]
13. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence.
Schlecht NF
Oncol Rep; 2005 Nov; 14(5):1239-47. PubMed ID: 16211291
[TBL] [Abstract][Full Text] [Related]
15. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma.
Capone RB; Pai SI; Koch WM; Gillison ML; Danish HN; Westra WH; Daniel R; Shah KV; Sidransky D
Clin Cancer Res; 2000 Nov; 6(11):4171-5. PubMed ID: 11106228
[TBL] [Abstract][Full Text] [Related]
16. Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines.
Nagel R; Martens-de Kemp SR; Buijze M; Jacobs G; Braakhuis BJ; Brakenhoff RH
Oral Oncol; 2013 Jun; 49(6):560-6. PubMed ID: 23578372
[TBL] [Abstract][Full Text] [Related]
17. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.
Spanos WC; Nowicki P; Lee DW; Hoover A; Hostager B; Gupta A; Anderson ME; Lee JH
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1137-46. PubMed ID: 19917928
[TBL] [Abstract][Full Text] [Related]
18. Current status of biomarkers in head and neck cancer.
Chang SS; Califano J
J Surg Oncol; 2008 Jun; 97(8):640-3. PubMed ID: 18493942
[TBL] [Abstract][Full Text] [Related]
19. Rethinking the head and neck cancer population: the human papillomavirus association.
Callaway C
Clin J Oncol Nurs; 2011 Apr; 15(2):165-70. PubMed ID: 21444283
[TBL] [Abstract][Full Text] [Related]
20. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience.
Singhi AD; Westra WH
Cancer; 2010 May; 116(9):2166-73. PubMed ID: 20186832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
